Glaukos Corporation , an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that ...

Diabetic retinopathy can lead to peripheral or nighttime vision loss, visual disturbances, and, if left untreated, blindness.

Adnexus Biotechnologies Inc. is proud to announce the launch of AI-Driven Neural Temporal Fingerprinting, a groundbreaking ...

This substantial investment reflects our commitment to delivering world-class eye and hearing care to Pembrokeshire,’ says ...

Specsavers Haverfordwest has relocated to a larger, state-of-the-art premises in the Riverside Shopping Centre, becoming the ...

Zone in the Awutu Senya District in the Central Region has been declared an "avoidable vision-loss free" community ...